Stocks › CTY

CITY THERAPEUTICS, INC.

CTY·Nasdaq·United States United States·USD
$19.32
+0.97 (+5.29%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
CTY
CITY THERAPEUTICS, INC. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CTYS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of CTY by members of U.S. Congress · 1 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Raúl M. GrijalvaRaúl M. GrijalvaHouse · D · AZ CTYCITY THERAPEUTICS, INC. · Stock Sale
$1,001 - $15,000
Feb 5, 2014 Jan 15, 2014 Filing ↗

Whale Activity

Position changes in CTY reported for 2020-12-31 by 1 institutional filer
Closed: 1
  • Increased0
  • New0
  • Held0
  • Decreased0
  • Closed1
  • No prior filing0
FilerSharesValueChange
CARY STREET PARTNER INVESTMENT ADVISORY LLC0$0closed

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by CTY insiders, by quarter · Form 4
-200.0K-100.0K0100.0K200.0K2025 Q1: 02025 Q12025 Q2: 02025 Q22025 Q3: 02025 Q32025 Q4: 02025 Q42026 Q1: 02026 Q12026 Q2: 02026 Q22026 Q3: 02026 Q32026 Q4: 170.0K2026 Q4

Recent Insider Transactions

2 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
ARCH Venture Partners XII, LLC / ARCH Venture Partners XII, L.P. / ARCH Venture Fund XII, L.P. / CRANDELL KEITH / Burow Kristina / GILLIS STEVEN Purchase +170.0K n/c — Oct 19, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding CTY · SEC Form N-PORT

No mutual fund or ETF has reported CTY in an N-PORT filing in the last seven months.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Abigail P. JohnsonSCHEDULE 13G · passive (13G) · 7.0M shares14.0%
    Nov 6, 2026 · ↗
  • FMR LLCSCHEDULE 13G · passive (13G) · 7.0M shares14.0%
    Nov 6, 2026 · ↗
  • Steven GillisSCHEDULE 13D · activist (13D) · 13.7M shares25.6%
    Oct 26, 2026 · ↗
  • Kristina BurowSCHEDULE 13D · activist (13D) · 13.7M shares25.6%
    Oct 26, 2026 · ↗
  • Keith CrandellSCHEDULE 13D · activist (13D) · 13.7M shares25.6%
    Oct 26, 2026 · ↗
  • Robert NelsenSCHEDULE 13D · activist (13D) · 13.7M shares25.6%
    Oct 26, 2026 · ↗
  • ARCH Venture Partners XII, LLCSCHEDULE 13D · activist (13D) · 13.7M shares25.6%
    Oct 26, 2026 · ↗
  • ARCH Venture Partners XII, L.P.SCHEDULE 13D · activist (13D) · 13.7M shares25.6%
    Oct 26, 2026 · ↗
  • ARCH Venture Fund XII, L.P.SCHEDULE 13D · activist (13D) · 13.7M shares25.6%
    Oct 26, 2026 · ↗
  • HALVORSEN OLE ANDREASSCHEDULE 13G · passive (13G) · 3.7M shares7.0%
    Oct 26, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming CITY THERAPEUTICS, INC. as client

No lobbying filings found naming CITY THERAPEUTICS, INC. as the client.

Government Contracts

Federal awards to CITY THERAPEUTICS, INC. · USAspending

No federal contract awards found for CITY THERAPEUTICS, INC..

U.S. Patents

Recent USPTO applications naming CITY THERAPEUTICS, INC.

No USPTO patent applications found for CITY THERAPEUTICS, INC..

Annual Financials

From CTY's 10-K filings · XBRL

SEC holds no annual XBRL figures in US dollars for CITY THERAPEUTICS, INC..

Stock Splits

Every split and reverse split in the price history

No stock splits in CTY's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 7.01, 9.01Reg FD disclosureNov 10, 2026
    EDGAR ↗
  • 8-K · Items 5.03, 9.01Bylaw amendmentOct 19, 2026
    EDGAR ↗

About CITY THERAPEUTICS, INC.

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersCAMBRIDGE, MA
IncorporatedDE